Should You Hold Aprea Therapeutics Inc (APRE) in Biotechnology Industry?

Friday, October 20, 2023 01:58 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Aprea Therapeutics Inc (APRE) in Biotechnology Industry?

Aprea Therapeutics Inc (APRE) is around the top of the Biotechnology industry according to InvestorsObserver. APRE received an overall rating of 55, which means that it scores higher than 55 percent of all stocks. Aprea Therapeutics Inc also achieved a score of 75 in the Biotechnology industry, putting it above 75 percent of Biotechnology stocks. Biotechnology is ranked 73 out of the 148 industries.

APRE has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on APRE!

See Full APRE Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 55 would rank higher than 55 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Aprea Therapeutics Inc Stock Today?

Aprea Therapeutics Inc (APRE) stock is trading at $4.30 as of 1:16 PM on Friday, Oct 20, a loss of -$0.66, or -13.31% from the previous closing price of $4.96. The stock has traded between $3.85 and $4.46 so far today. Volume today is above average. So far 40,660 shares have traded compared to average volume of 13,464 shares. Click Here to get the full Stock Report for Aprea Therapeutics Inc stock.